These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2459953)
1. Tumor markers for ovarian cancer. A comparative immunohistochemical and immunocytochemical study of two commercial monoclonal antibodies (OV632 and OC125). Koelma IA; Nap M; van Steenis GJ; Fleuren GJ Am J Clin Pathol; 1988 Oct; 90(4):391-6. PubMed ID: 2459953 [TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical detection of ovarian carcinoma cells in serous effusions. Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129 [TBL] [Abstract][Full Text] [Related]
3. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma. Delahaye M; Hoogsteden HC; Van der Kwast TH J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800 [TBL] [Abstract][Full Text] [Related]
4. Immunohistological characterization of a monoclonal antibody (OV632) against epithelial ovarian carcinomas. Fleuren GJ; Coerkamp EG; Nap M; vd Broek LJ; Warnaar SO Virchows Arch A Pathol Anat Histopathol; 1987; 410(6):481-6. PubMed ID: 3105167 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical staining of ovarian tumours with Ov632. Owens OJ; Mutch F Cytopathology; 1992; 3(3):161-6. PubMed ID: 1511121 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies]. Bar J; Sobańska E Ginekol Pol; 1994 Sep; 65(9):502-7. PubMed ID: 7721163 [TBL] [Abstract][Full Text] [Related]
7. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Kabawat SE; Bast RC; Welch WR; Knapp RC; Colvin RB Am J Clin Pathol; 1983 Jan; 79(1):98-104. PubMed ID: 6336888 [TBL] [Abstract][Full Text] [Related]
8. Relation between ovarian carcinoma-associated antigens in tumor tissue and detached cyst fluid cells of patients with ovarian neoplasms. Bar JK; Harłozińska A; Sobańska E; Cislo M Tumori; 1994 Feb; 80(1):50-5. PubMed ID: 8191599 [TBL] [Abstract][Full Text] [Related]
9. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions. Bassarova AV; Nesland JM; Davidson B Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331 [TBL] [Abstract][Full Text] [Related]
10. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells. Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721 [TBL] [Abstract][Full Text] [Related]
11. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms. Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907 [TBL] [Abstract][Full Text] [Related]
12. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575 [TBL] [Abstract][Full Text] [Related]
13. Marker profile of mesothelial cells versus ovarian carcinoma cells. van Niekerk CC; Jap PH; Thomas CM; Smeets DF; Ramaekers FC; Poels LG Int J Cancer; 1989 Jun; 43(6):1065-71. PubMed ID: 2659540 [TBL] [Abstract][Full Text] [Related]
14. Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells. Xu FJ; Yu YH; Li BY; Moradi M; Elg S; Lane C; Carson L; Ramakrishnan S Cancer Res; 1991 Aug; 51(15):4012-9. PubMed ID: 1855217 [TBL] [Abstract][Full Text] [Related]
15. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells. Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184 [TBL] [Abstract][Full Text] [Related]
16. Ovarian carcinoma metastasis to the breast case report and review of the literature. Yamasaki H; Saw D; Zdanowitz J; Faltz LL Am J Surg Pathol; 1993 Feb; 17(2):193-7. PubMed ID: 8422114 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids. Afify A; Zhou H; Howell L; Paulino AF Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies. Ménard S; Rilke F; Della Torre G; Mariani-Costantini R; Regazzoni M; Tagliabue E; Alasio L; Colnaghi MI Am J Clin Pathol; 1985 May; 83(5):571-6. PubMed ID: 3887893 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report. Wasserman L; Neri A; Kaplan B; Manor Y; Galli M; Hardy B J Cancer Res Clin Oncol; 1995; 121(7):387-92. PubMed ID: 7543483 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the specificity by immunohistology of a monoclonal antibody to a novel epithelial antigen of ovarian carcinomas. Mariani-Costantini R; Agresti R; Colnaghi MI; Ménard S; Andreola S; Rilke F Pathol Res Pract; 1985 Aug; 180(2):169-80. PubMed ID: 3903701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]